Weekly insulin shots can help control both type 1 and type 2 diabetes as well as daily injections do, a pair of clinical trials have found.

A new class of insulin called efsitora alfa has been designed to require injections only once a week, researchers said.

Two phase 3 trials presented Tuesday at the ...

Insulin can be a critical part of managing diabetes, but patients may not know all of the ins and outs of using the medication effectively.

Luckily, the American Diabetes Association (ADA) has plenty of information and tips on using insulin.

First, there are different types of insulin, depending on how fast they work, when they peak and how long they last. Insulin is also ...

Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows.

Patients using inhaled insulin (Afrezza) plus long-lasting

Managing a stroke victim's blood sugar levels after they receive powerful clot-busting drugs might help them survive their health crisis, a new trial finds.

People with high blood sugar levels were more likely to suffer a potentially deadly brain bleed after clot-busters reopened their blocked brain arteries, researchers found.

The risk was particularly high in older patients with m...

An immune-compromised man with a year-and-a-half-long COVID infection served as a breeding ground for dozens of coronavirus mutations, a new study discovered.

Worse, several of the mutations were in the COVID spike protein, indicating that the virus had attempted to evolve around current vaccines, researchers report.

"This case underscores the risk of persistent SARS-CoV-2 infection...

There may be an unexpected fix for ongoing shortages of insulin: A brown bovine in Brazil recently made history as the first transgenic cow able to produce human insulin in her milk.

"Mother Nature designed the mammary gland as a factory to make protein really, really efficiently," explained study leader Matt Wheeler, a professor ...

Managing diabetes will be a less expensive proposition for more Americans in 2024.

Sanofi has officially joined Novo Nordisk and Eli Lilly in lowering the cost of insulin to $35 a month for many patients. The three drugmakers are also drastically lowering the list prices for their insulin pr...

People with type 1 diabetes lack functional islet cells in their pancreas to produce the hormone insulin and must take daily insulin via injections or a continuous pump to compensate.

But if new research pans out, some folks with type 1 diabetes may no longer need ...

Recent research has suggested that viruses could play a role in the loss of pancreatic beta cells, which triggers type 1 diabetes.

Now, a new trial finds antiviral medications, when given soon after a child is diagnosed with type 1 diabetes, might help preserve those vital beta cells.

Antiviral drugs could be "used alone, or as part of combination treatment regimens, to rescue insu...

The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop their daily insulin shots.

Experts emphasized that the findings

People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required.

A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3 clinical trial results show.

Icodec now awaits approval by the U.S. Food and Drug Administration based on these results, ...

Could a one-hour procedure that involves zapping a part of the intestines mean no more insulin for millions of folks with type 2 diabetes?

Maybe, according to a small study scheduled for presentation next week at the Digestive Disease Week meeting in Chicago.

The new minimally invasive procedure used controlled electrical pulses to change the lining of the first part of the small i...

Sanofi Inc. on Thursday became the third company to announce it will slash prices on its insulin products.

The French company announced that it will cut prices by 78% and cap out-of-pocket charges for its insulin, brand named Lantus, at $35 per month. The company will also lower prices on its short-acting insulin, Apidra, by 70%.

"Sanofi believes that no one should struggle to pay f...

Novo Nordisk Inc. on Tuesday became the third drug company to say it will slash prices on some of its insulin products.

Starting in January 2024, there will be a 75% price cut for NovoLog and NovoLog Mix 70/30, while Novolin and Levemir will see cuts of 65%, the Danish pharmaceutical giant announced in a